“Critical” Drug List Would Be Created Under Shortages Bill
This article was originally published in The Pink Sheet Daily
Draft bill being developed by Rep. John Carney, D-Del., also would create system to notify the public and other manufacturers of pending shortages.
You may also be interested in...
Preventing shortages through increased communications with manufacturers could gain the upper hand in part because creating economic incentives may prove too difficult and controversial.
Like the Senate proposal, it could include reimbursement rate adjustments in addition to requiring early notification of shortages by manufacturers, but questions remain about ensuring there are no unintended consequences.
At Senate hearing, the agency says an executive order has helped spur notifications, while the GAO suggests Congress require manufacturers to tell FDA about anything that could affect the drug supply. Reimbursement changes will not solve the shortage problem, an HHS official argues.